ERBA Diagnostics, Inc. Appoints Hayden Jeffreys as Interim Chief Executive Officer
November 29, 2016 16:30 ET
|
ERBA Diagnostics, Inc.
MIAMI, Nov. 29, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (OTC PINK:ERBA) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, effective as of January 1,...
ERBA Diagnostics to Commence Trading on OTC Markets’ Pink Open Market After Delisting by the NYSE MKT
September 30, 2016 16:00 ET
|
ERBA Diagnostics, Inc.
MIAMI, Sept. 30, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (the “Company”), a fully integrated in vitro diagnostics company, previously disclosed that the Company expected the NYSE MKT LLC...
ERBA Diagnostics, Inc. Announces Inability to Meet Deadline to Regain Compliance With NYSE MKT Continued Listing Standards
September 29, 2016 16:05 ET
|
ERBA Diagnostics, Inc.
MIAMI, Sept. 29, 2016 (GLOBE NEWSWIRE) -- As previously reported, ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, implemented during the third...
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
August 26, 2016 16:15 ET
|
ERBA Diagnostics, Inc.
MIAMI, Aug. 26, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on August 23, 2016, the Company...
ERBA Diagnostics, Inc. Announces Extension of CEO’S Contract Term and Appointment of Hayden Jeffreys to Board of Directors
May 31, 2016 16:15 ET
|
ERBA Diagnostics, Inc.
MIAMI, May 31, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that it has entered into an amendment...
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan
May 20, 2016 16:15 ET
|
ERBA Diagnostics, Inc.
MIAMI, May 20, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on May 19, 2016, the Company...
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
April 21, 2016 16:45 ET
|
ERBA Diagnostics, Inc.
MIAMI, April 21, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on April 15, 2016, the Company...
ERBA Diagnostics’ Compliance Plan Accepted by NYSE MKT
January 27, 2016 08:00 ET
|
ERBA Diagnostics, Inc.
MIAMI, Jan. 27, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that the Company received a letter...
ERBA Diagnostics, Inc. Announces the Consummation of the Capital Infusion of $3.5 Million Into the Company
December 29, 2015 08:05 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., Dec. 29, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, has consummated the capital infusion of...
ERBA Diagnostics Inc. Annual General Meeting CEO’s Speech on the Company’s Progress in 2015
December 17, 2015 08:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., Dec. 17, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) At ERBA Diagnostics, Inc.’s annual meeting of stockholders held on December 15, 2015, Mohan Gopalkrishnan,...